Medtech Insight and Windhover Information's 2006 ''Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies''; Premier International Networking Meeting Has Limited Space Still Available.

NORWALK, Conn. -- September 18-20, 2006 Crowne Plaza, Brussels City Centre, Belgium

The highest-profile networking and informational meeting of the year for international biotech companies is set to begin in just one week on Monday, Sept. 18, in Brussels, Belgium. The biggest dealmakers in the American and European markets will be on hand for "Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies," sponsored by Medtech Insight, a division of Windhover Information.

Hundreds of senior-level decision-makers from most of the major medtech companies and healthcare investment firms worldwide will be on hand for the event.

With the landmark event only one week away, there are a few spaces remaining, and registrations can be made at http://www.medtechinsight.com/in3-europe-02.html.

Huge Array of Global Companies Signed up to Attend

Companies registered to attend to date include 3i, 3i Group PLC, Abbott Laboratories, ABMI SA, AION Diagnostics Ltd., Arbel Medical Ltd., Arrow International Inc., Aubrey Group Inc., Battelle - Health and Life Sciences, Baxter R&D Europe, BioImagene Inc., Biosan Medical Ltd., Blue Corporate Finance GmbH & Co KG, BOC Group (MEdical), Boston Scientific International SA, C.R. Bard Inc., Card Guard Scientific Survival Ltd., Cardinal Health, Cardio3 SA, Cheetah Medical Inc., Datascope, Delta Partners, Diagnostic Devices Inc. (DDI), Dialog Devices Ltd., DSM New Business Development, Earlybird Ventures, EBD Group, Factory CRO, Factory CRO for Clinical Research, Ferrosan A/S, Giza Venture Capital, Global Orthopaedic Technology Pty Ltd, HealthLink Europe, IIC GmbH, Imperial College London, Inion Oy, Innovate UK, InspireMD, Investor Growth Capital Inc., Itochu International Inc., Johnson & Johnson Development Corp., Kobayashi Medical, Krauth Medical, KG (GmbH & Co.), Kyphon Europe BVBA, Lapeyre Industries, Matignon Technologies FCPR, Medica Venture Partners, Medical Capital Advisors, Medical Capital Advisors LLC, Medtronic Inc., mNemoscience GmbH, Morgan Stanley, Morris Innovative Research, Naiot Technological Center Ltd., Novashunt Inc., OZ Recovery Technologies Ltd., Pitango Venture Capital, PreSRV Ltd., Protomed SARL, Provista Life Sciences LLC, Ronald Trahan Associates Inc., Sorin S.p.A., SPEF Venture, Stentys, Stryker Orthopaedics, SutureAid Inc., Synectic Engineering Inc., Synovis Life Technologies, Tibion Corporation, Triage Medical Inc., Tyco Healthcare, Victhom Human Bionics Inc., and WideMed Ltd.

Keynote Speakers, Discussions Tackle Crucial Issues

In addition to invaluable networking and partnering, In3 Europe will feature a number of eminent healthcare executives as speakers and an in-depth industry panel discussion.

The agenda includes:

--"Best Practices for Venture Investing in Europe" with Michel Lussier, CEO of MedPole, Chairman of Cardio3 and VP & General Manager of European Operations for Volcano

--"Medtech Investing in Europe: the 3i Perspective" with Andrew Fraser, Partner, 3i

--"The European Route: First CE-mark and then FDA approval; does it make sense?" with Dirk Meijer, M.D., Ph.D., CEO, Factory CRO

--"What Makes Israel Such a Dynamic Device Company Developer?" panel discussion with Zeev Zehavi, Vice President, Johnson & Johnson Development Corporation; Yuval Binur, Ph.D., Chairman of the Board, Accelerated Technologies; Nissim Darvish, M.D., DSc., Partner, Pitango Venture Capital; and Avi Molcho, M.D., Managing Director, Life Sciences, Giza Venture Capital

--"The Seven Drivers of Value: Optimize Your VC Funding and Exit" panel discussion to be moderated by Christopher J.P. Velis, Chairman & CEO, Medical Capital Advisors

--"Late-Stage Dealmaking: Venture Capital Perspectives"

--"Exit Strategy Case Studies Panel: Getting Sold vs. Going Public"

--"Venture Capital Investing in Medical Technology Companies - 2006 State of Affairs"

For a complete agenda, visit http://www.medtechinsight.com/Agenda-in3-europe-02.html.

Intriguing Array of Presenting Companies

More than 30 emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership opportunities are schedule to present at the conference. Presenters will be on hand from the U.S., Europe, Israel and Australia. A complete list of presenters is available at http://www.medtechinsight.com/in3-europe-02.html#presenters.

The forum will provide focused overviews by a senior executive from each presenting company, followed by the opportunity to meet one-on-one in private breakout rooms, along with one-on-one meetings with company representatives in private breakout rooms and table-top exhibits and product prototypes by presenting companies during a networking dinner.

Co-sponsors for In3 Europe include 3i, Battelle, Business Wire, Factory, Medical Capital Advisers, Ronald Trahan Associates and T for G.

Registrations Now Being Accepted

Medtech Insight's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past five years. Participating companies send multiple attendees, including company presidents, CEOs, partners, and VPs for business development, marketing, acquisitions, corporate development and R&D.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, or 888-202-5939 toll-free in the U.S.; e-mail [e-mail]; or register on the In3 Europe website at http://www.medtechinsight.com/in3-europe-02.html.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.